The invention discloses a nasal delivery double-chain
RNA / Mn < 2 + > nano-
drug as well as a preparation method and application thereof in
immunotherapy. And adding the
polymer into a solution containing double-stranded
RNA and
manganese salt, and self-assembling to form the nasal delivery double-stranded
RNA / Mn < 2 + > nano-
drug. The invention provides a new technical scheme for the barrier of the BBB. The nano
delivery system has the advantages in the aspects of overcoming the BBB and improving the in-vivo biological distribution of the
drug, and the surface of the nano carrier is modified with a ligand targeted to an endothelial
cell overexpression
receptor, such as ApoE
peptide and the like, so that the drug can be delivered to penetrate through the BBB; a non-invasive nasal-brain delivery strategy becomes a new scheme for improving
drug availability and reducing toxic and side effects, the drug can bypass BBB and rapidly enter brain
parenchyma through olfactory
bulb and
trigeminal nerve conduction pathways, and an immune drug delivered by the
nasal cavity can rapidly enter nasopharynx-related lymphatic tissue (NALT) and is transferred to CLN through a lymphatic network around the
nasal cavity, so that the immune drug can be rapidly delivered to the nasopharynx-related lymphatic tissue (NALT). Further, a potent local immune response aiming at the in-situ GBM is induced.